Key Highlights
- Q2 revenue rose 19% year over year to $2.89 billion.
- Procedure volume grew 16%, with 468 da Vinci systems installed.
- Non-GAAP earnings per share came in at $2.80.
- Shares closed down 14% at $345.42 despite the results.
Intuitive Surgical (NASDAQ: ISRG) shares closed down 14% at $345.42 after the company reported second-quarter revenue of $2.89 billion, up 19% from a year earlier, driven by higher procedure volumes and continued rollout of its newest surgical platform.
What Happened
Revenue growth was bolstered by a 16% rise in procedure volume performed on the company's robotic-assisted surgical systems and by the installation of 468 da Vinci systems during the quarter.
The continued rollout of the da Vinci 5 platform contributed to the quarter's results, alongside non-GAAP earnings per share of $2.80.
The company also used $380 million during the quarter for share buybacks.
Market Reaction
Intuitive Surgical, a large-cap medical device company, saw shares fall 14% to close at $345.42 despite reporting double-digit growth across revenue and procedure volume.
The decline came even as the company reported $380 million in share buybacks during the quarter, a use of capital typically associated with confidence in the underlying business.
Outlook
The disclosed information does not include specific forward guidance beyond the reported second-quarter results and the continued rollout of the da Vinci 5 platform.
Why did Intuitive Surgical stock fall after strong earnings?
The disclosed information shows Q2 revenue grew 19% to $2.89 billion and procedure volume rose 16%, yet shares still closed down 14% at $345.42.
How many da Vinci systems did Intuitive Surgical install in Q2?
The company installed 468 da Vinci systems during the quarter.
What was Intuitive Surgical's non-GAAP EPS in Q2?
Non-GAAP earnings per share came in at $2.80 for the quarter.


_11_17_2026_13_39_08_971706.jpg)



Please wait processing your request...